0001209191-22-034826.txt : 20220607
0001209191-22-034826.hdr.sgml : 20220607
20220607160805
ACCESSION NUMBER: 0001209191-22-034826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saad Mark E
CENTRAL INDEX KEY: 0001295913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 221001304
BUSINESS ADDRESS:
BUSINESS PHONE: 858-458-0900
MAIL ADDRESS:
STREET 1: C/O CYTORI THERAPEUTICS, INC.
STREET 2: 3020 CALLAN ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001295913
Saad Mark E
C/O AXSOME THERAPEUTICS, INC.
22 CORTLANDT STREET, 16TH FLOOR
NEW YORK
NY
10007
1
0
0
0
Stock Option (Right to Buy)
25.53
2022-06-03
4
A
0
16976
0.00
A
2023-06-03
2032-06-03
Common Stock
16976
16976
D
The option vests in full on the one-year anniversary of the date of grant, June 3, 2023.
/S/ Herriot Tabuteau, M.D., Attorney-in-Fact
2022-06-07